ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4213 |  RPID Rapid Micro Biosystems, Inc. - Class A Common Stock | 0.85 USD | +3.66% | -3.41% | -24.78% | -70.49% | 42.64 M USD | ||
| 4217 |  DWTX Dogwood Therapeutics, Inc. - Common Stock | 1.25 USD | -0.79% | -13.79% | -30.56% | -58.33% | 42.49 M USD | ||
| 4219 |  XTNT Xtant Medical Holdings, Inc. Common Stock | 0.30 USD | -3.23% | -6.25% | -6.25% | -50.82% | 42.09 M USD | ||
| 4223 |  VERU Veru Inc. - Common Stock | 2.44 USD | +14.55% | +0.83% | +3.83% | +2.09% | 41.60 M USD | ||
| 4225 |  TIL Instil Bio, Inc. - Common Stock | 6.13 USD | +3.03% | -9.32% | -16.14% | -68.55% | 41.57 M USD | ||
| 4231 |  GRCE Grace Therapeutics, Inc. - Common Stock | 1.95 USD | +3.17% | -4.88% | -13.33% | -51.01% | 41.02 M USD | ||
| 4237 |  PRPO Precipio, Inc. - Common Stock | 22.54 USD | +1.03% | -2.63% | -16.46% | +7.38% | 40.35 M USD | ||
| 4244 |  BTMD Biote Corp. - Class A common stock | 1.11 USD | -1.77% | -5.13% | -18.38% | -61.32% | 39.88 M USD | ||
| 4255 |  SCYX SCYNEXIS, Inc. - Common Stock | 3.91 USD | -1.26% | -6.68% | -4.87% | +401.28% | 38.90 M USD | ||
| 4260 |  NEPH Nephros, Inc. - Common Stock | 3.51 USD | -0.28% | +5.41% | -17.61% | -32.50% | 38.12 M USD | ||
| 4264 |  EXOZ eXoZymes Inc. - Common Stock | 4.00 USD | -13.04% | -25.09% | -34.43% | -58.76% | 37.13 M USD | ||
| 4266 |  CVRX CVRx, Inc. - Common Stock | 1.39 USD | +3.73% | -16.27% | -54.28% | -85.23% | 37.03 M USD | ||
| 4268 |  CALC CalciMedica, Inc. - Common Stock | 1.08 USD | +0.93% | -16.92% | -44.62% | -66.56% | 36.87 M USD | ||
| 4273 |  HBIO Harvard Bioscience, Inc. - Common Stock | 8.03 USD | -1.47% | -0.86% | +0.37% | +1858.54% | 36.56 M USD | ||
| 4274 |  LITS Lite Strategy, Inc. - Common Stock | 1.20 USD | +2.56% | -4.00% | +12.15% | -35.14% | 36.49 M USD | ||
| 4275 |  STRR Star Equity Holdings, Inc. - Common Stock | 9.88 USD | +0.61% | +0.51% | -5.90% | -8.09% | 36.45 M USD | ||
| 4277 |  IXHL Incannex Healthcare Inc. - Common Stock | 2.88 USD | +0.70% | -9.15% | -24.01% | +722.86% | 36.13 M USD | ||
| 4287 |  NNVC NanoViricides, Inc. Common Stock | 1.38 USD | +4.55% | +3.76% | +5.34% | +36.63% | 35.22 M USD | ||
| 4291 |  QTI QT Imaging Holdings, Inc. - Common Stock | 2.38 USD | -4.80% | -7.39% | -10.19% | -60.98% | 34.83 M USD | ||
| 4297 |  COSM Cosmos Health Inc. - Common Stock | 0.34 USD | -10.53% | +9.68% | +25.93% | -67.92% | 34.22 M USD |
ニュース ヘルスケア株
Gate、NeoSoul（DNA）の契約・レバレッジ・スワップ・コピートレードなど複数サービスを上場
Curis、1,666万6,000株の普通株式とワラントを1株当たり0.51ドルで約850万ドル規模で募集開始
タンゴ・セラピューティクス、ESMO Congress 2026において、MTAPdel/RASmut転移性膵管腺癌（PDAC）および非小細胞肺癌（NSCLC）患者を対象とした、ボピメトスタットとダラキソンラシブまたはゾルドンラシブの併用による第1/2相試験の最新データを発表へ
Fractyl HealthのREMAIN-1試験、6カ月の共同主要評価項目を高い統計学的有意性で達成；GLP-1誘導による減量の80%を維持し、シャム群の67%を上回ることを示す
ゴールドマン・サックスがエランコ・アニマルヘルスのカバレッジを開始、投資判断「買い」、目標株価32ドルを発表
バイナンスAlpha、本日16:00にNeoSoul（DNA）を上場へ。245ポイント以上保有で400 DNAを請求可能
UBS、Solid Biosciencesのカバレッジを開始、投資判断は「買い」、目標株価20ドルを発表
上昇銘柄ヘルスケア株
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
下落銘柄ヘルスケア株
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |